Drug Shortage Report for M-LATANOPROST-TIMOLOL

Last updated on 2025-03-03 History
Report ID 245408
Drug Identification Number 02514516
Brand name M-LATANOPROST-TIMOLOL
Common or Proper name M-LATANOPROST-TIMOLOL
Company Name MANTRA PHARMA INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2.5 ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-12-02
Estimated end date 2025-02-28
Actual end date 2025-02-27
Shortage status Resolved
Updated date 2025-03-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-03-03 French Compare
v5 2025-03-03 English Compare
v4 2025-01-03 French Compare
v3 2025-01-03 English Compare
v2 2024-12-11 French Compare
v1 2024-12-11 English Compare

Showing 1 to 6 of 6